NeoGenomics Raises 2026 Guidance to $807M-$809M as CEO Transition Plans in January 2027 (NASDAQ:NEO)
NeoGenomics Raises 2026 Guidance to $807M-$809M as CEO Transition Plans in January 2027 (NASDAQ:NEO)
Want to see every report in real time?
Hundreds of sources worldwide, translated into your language, with alerts for what matters to you.
Sign up free Already have an account? Log in